Retinal 0.2% Emulsion

There’s a hierarchy in the retinoid world that most skincare consumers eventually learn: retinyl esters at the bottom (gentle, slow), retinol in the middle (effective, established), retinaldehyde near the top (potent, underserved), and prescription retinoic acid at the summit (powerful, gatekeeper-controlled). For years, that hierarchy had a conspicuous gap. Retinol was everywhere — in every price range, every formulation, every brand. Retinaldehyde, despite being demonstrably more potent and sitting just one enzymatic conversion from the prescription form, was available from perhaps a handful of brands, mostly European, mostly expensive, and mostly unknown outside dermatology circles.

The Ordinary looked at that gap and did what The Ordinary does: filled it at a price that made every other retinaldehyde product’s margins suddenly uncomfortable.

The Retinal 0.2% Emulsion is not just retinaldehyde in a bottle. The formulation reveals a level of technological sophistication that goes beyond The Ordinary’s usual approach of “active ingredient plus minimal vehicle.” The retinaldehyde is encapsulated in hydroxyapatite — a biocompatible calcium phosphate mineral that’s a natural component of human bone and teeth. This isn’t decorative science. Free retinaldehyde on skin causes an irritation spike as the full concentration hits the surface at once. Hydroxyapatite encapsulation creates a sustained-release mechanism: the retinal is gradually liberated from the mineral matrix over time, delivering a steady dose rather than a burst. The peak irritation is lower while the cumulative efficacy is maintained.

Around this encapsulated retinal, The Ordinary has built a deliberate irritation-management system. Cetylhydroxyproline palmitamide — a synthetic oat analogue — mimics the barrier-soothing properties of colloidal oatmeal, directly counteracting the dryness and barrier disruption that retinoids cause. Bisabolol, derived from chamomile, provides anti-inflammatory support through a separate pathway. Ergothioneine, a potent amino acid antioxidant, protects both the retinaldehyde from oxidative degradation and the skin from the oxidative stress that accelerated cell turnover can generate. This isn’t a formula that delivers retinaldehyde and hopes for the best — it’s a formula that anticipates retinaldehyde’s problems and addresses them within the same bottle.

The potency deserves honest framing. Retinaldehyde is approximately 11 times more bioactive than retinol at equivalent concentrations, according to published research. At 0.2%, this emulsion delivers potency roughly comparable to 1-2% retinol — firmly in the advanced territory. The 0.2% number can be misleading: it sounds gentle, almost introductory. It is not. This is a product for people who have already spent months building retinoid tolerance with retinol and are ready for the next step. Using this as your first retinoid experience is like learning to drive in a sports car — technically possible, almost certainly unpleasant.

The texture is a pleasant surprise for a retinoid product. A lightweight, milky emulsion with a faint yellow tint from the retinaldehyde, it absorbs smoothly without the heaviness or greasiness that characterizes many retinoid creams. The emulsion base provides enough occlusion to support the retinoid’s delivery without sitting on the skin’s surface. Under a moisturizer — which you should absolutely apply after this product — it layers cleanly.

Results come faster than retinol. This is the primary argument for retinaldehyde: with one fewer enzymatic conversion required, the active form reaches retinoic acid receptors more efficiently. Texture refinement is visible within two weeks. Fine lines and firmness improvements appear at four to six weeks. Significant dark spot fading, pore refinement, and overall skin quality transformation at eight to twelve weeks. These timelines are approximately 30-40% faster than equivalent retinol results for most users — a meaningful acceleration for an active that traditionally requires patience.

The irritation is real and should not be minimized. Even with the hydroxyapatite encapsulation and soothing ingredients, 0.2% retinaldehyde will cause some degree of dryness, peeling, and redness during the retinization period (typically weeks 2-6). Starting at once weekly and progressing to twice weekly over a month is essential — not optional. The yellow tint can stain lighter pillowcases, which is a practical annoyance. And the 15ml bottle, while standard for a high-concentration retinoid, feels small when the product lasts only two to three months at the recommended twice-weekly usage.

At $14.90, the value proposition is striking. Comparable retinaldehyde products — from Avène, Medik8, and A313 — typically cost $40-80 for similar concentrations. The Ordinary delivers equivalent potency with arguably superior delivery technology (the hydroxyapatite encapsulation) and a more comprehensive soothing system at roughly one-third to one-fifth the price. For a retinoid that’s been inaccessible to most consumers due to pricing and availability, this democratization is significant.

The Retinal 0.2% Emulsion is not The Ordinary’s easiest product to use, its most universally suitable, or its most instantly gratifying. It’s their most scientifically ambitious — a high-potency retinoid with delivery technology that competes with formulations costing five times as much. For experienced retinoid users who’ve plateaued on retinol and want to progress without jumping to prescription tretinoin, this product fills a space that barely existed before it arrived.